Disis Immunotherapy of Cancer

2006
ISBN: 978-1-59745-011-9
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 516 Seiten, eBook

Reihe: Cancer Drug Discovery and Development

Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Disis, Mary L.

Inhaltsverzeichnis

Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches Özlem Türeci, Thorsten Klamp, Michael Koslowski, Sebastian Kreiter, and Ugur Sahin Current Strategies for the Identification of Immunogenic Epitopes of Tumor Antigens Ludmila Müller, Stephanie McArdle, Evelyna Derhovanessian, Thomas Flad, Ashley Knights, Robert Rees, and Graham Pawelec Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy Lisa M. Harlan and Julie Y. Djeu The Role of Immune Monitoring in Evaluating Cancer Immunotherapy Holden T. Maecker Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials Susan Groshen DNA Vaccines for Cancer Immunotherapy Heesun Kwak and Howard L. Kaufman Dendritic Cells Weiping Zou and Tyler J. Curiel Different Approaches to Dendritic Cell-Based Cancer Immunotherapy Noweeda Mirza and Dmitry Gabrilovich Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer Malaya Bhattacharya-Chatterjee, Nitin Rohatgi, Sunil K. Chatterjee, Asim Saha, Rakesh Shukla, and Kenneth A. Foon Autologous Tumor-Derived Heat Shock Protein Vaccine as a New Paradigm for Individualized Cancer Therapeutics Jie Dai and Zihai Li Tumor-Reactive T-Cells for Adoptive Immunotherapy Helga Bernhard, Julia Neudorfer, Kerstin Gebhard, Heinke Conrad, Dirk H. Busch, and Christian Peschel T-Cell Adoptive Immunotherapy of Cancer: From Translational Models to Clinical Significance Peter A. Cohen, Mohamed Awad, and Suyu Shu Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells Jeffrey J. Roszkowski and Michael I. Nishimura Harnessing the Potential of Graft-vs-Tumor Nancy M. Hardy and Michael R. Bishop Tumor-Induced Immune Suppression and Immune Escape: Mechanisms and Impact on the Outcome ofImmunotherapy of Malignant Disease Michael Campoli and Soldano Ferrone The Tumor Microenvironment: Regulation of Antitumor Immunity and Implications for Immunotherapy George Coukos and Jose-Ramon Conejo-Garcia Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity Eduardo Davila and Esteban Celis Fast-Lane Evolution in the Tumor Microenvironment Gabriella Marincola and Francesco M. Marincola Manipulating Immunological Checkpoints to Maximize Antitumor Immunity Leisha A. Emens, R. Todd Reilly, and Elizabeth M. Jaffee Interleukin-2 as Cancer Therapy Joseph I. Clark and Kim A. Margolin Biological and Clinical Properties of the Type 1 Interferons Douglas W. Leaman, Shaun Rosebeck, and Ernest C. Borden Promising g-Chain Cytokines for Cancer Immunotherapy: Interleukins-7, -15, and -21 as Vaccine Adjuvants, Growth Factors and Immunorestoratives Terry J. Fry and Crystal L. Mackall The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies Sherif S. Farag and Michael A. Caligiuri Antibody Therapy for Solid Tumors Cristina I. Truica, Dorinda Rouch, and Carlos L. Arteaga Antibody Therapy for Non-Hodgkin's Lymphoma Stephen M. Ansell and Thomas E. Witzig Approaches to In Vivo Imaging of Cancer Immunotherapy George A. Vielhauer, Bond Almand, Mary L. Disis, David A. Mankoff, and Keith L. Knutson Design Issues for Early-Stage Clinical Trials for Cancer Vaccines Gina R. Petroni Monoclonal Antibody Therapy of Cancer Hossein Borghaei, Matthew K. Robinson, and Louis M. Weiner Index